Rafael San Juan Garrido-rekin lankidetzan egindako argitalpenak (20)

2024

  1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update

    Transplantation Reviews, Vol. 38, Núm. 4

2021

  1. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

2020

  1. A New Clinical and Immunovirological Score for Predicting the Risk of Late Severe Infection in Solid Organ Transplant Recipients: The CLIV Score

    The Journal of infectious diseases, Vol. 222, Núm. 3, pp. 479-487

  2. Executive summary of the Consensus Statement of the Transplant Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the National Transplant Organization (ONT) on the Selection Criteria of Donors of Solid Organs in relation to Infectious Diseases

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 8, pp. 379-389

  3. Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: The impact of cytomegalovirus disease and lymphopenia

    American Journal of Transplantation, Vol. 20, Núm. 6, pp. 1629-1641

  4. Selection criteria of solid organ donors in relation to infectious diseases: A Spanish consensus

    Transplantation Reviews, Vol. 34, Núm. 2

2019

  1. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2018

  1. Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 32, Núm. 1, pp. 36-57

2017

  1. Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey

    Transplant Infectious Disease, Vol. 19, Núm. 6

  2. Pathogen-related factors affecting outcome of catheter-related bacteremia due to methicillin-susceptible Staphylococcus aureus in a Spanish multicenter study

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 10, pp. 1757-1765

2016

  1. High MICs for vancomycin and daptomycin and complicated catheter-related bloodstream infections with methicillin-sensitive Staphylococcus aureus

    Emerging Infectious Diseases, Vol. 22, Núm. 6, pp. 1057-1066

  2. Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

    Transplantation Reviews, Vol. 30, Núm. 3, pp. 119-143

2015

  1. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  2. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

2011

  1. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients Recomendaciones GESITRA-SEIMC/REIPI para el manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 10, pp. 735-758

  2. Selective intestinal decontamination with fluoroquinolones for the prevention of early bacterial infections after liver transplantation

    Liver Transplantation, Vol. 17, Núm. 8, pp. 896-904

  3. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients

    Transplantation, Vol. 92, Núm. 3, pp. 346-350

2009

  1. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients

    Transplantation, Vol. 87, Núm. 3, pp. 424-435

2008

  1. Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation

    Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882

2005

  1. Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study

    Clinical Infectious Diseases, Vol. 41, Núm. 1, pp. 52-59